Literatur
- Bartova, L., et al. (2021). Ketamine for Treatment-Resistant Depression: A Meta-Analysis. Journal of Psychiatric Research, 141, 340–351.
- Duman, R. S., et al. (2012). A Neurotrophic Model for Stress-Related Mood Disorders. Nature Neuroscience, 15, 865–872.
- Murrough, J. W., et al. (2013). Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression. Biological Psychiatry, 74, 250–256.
- Wilkinson, S. T., et al. (2017). The Effect of a Single Dose of Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. American Journal of Psychiatry, 174, 150–158.
- Short, B., et al. (2018). Side Effects and Safety of Ketamine in Depression Treatment. The Lancet Psychiatry, 5, 65–78.
- Wilkinson, S. T., et al. (2018). Maintenance Ketamine Infusions for Treatment-Resistant Depression. American Journal of Psychiatry, 175, 303–311.
- Dakwar, E., et al. (2014). Ketamine Infusions for the Treatment of Cocaine Dependence: A Randomized Controlled Pilot Study. American Journal of Psychiatry, 171, 1136–1144.
- Feder, A., et al. (2014). Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder. JAMA Psychiatry, 71, 681–688.
- Cohen, S. P., et al. (2018). Ketamine in Chronic Pain Management: An Evidence-Based Review. Anesthesia & Analgesia, 126(6), 1783–1802.
- Bhat, A., et al. (2021). Potential Role of Ketamine in the Management of Long COVID. Neuropsychopharmacology, 46(1), 1–3.
- Krupitsky, E. M., et al. (2002). The Use of Ketamine in the Therapy of Alcoholism and Alcohol Dependence. Journal of Substance Abuse Treatment, 23, 273–283.
- Short, B., et al. (2018). Side Effects and Safety of Ketamine in Depression Treatment. The Lancet Psychiatry, 5, 65–78.
.svg)
